Feature Channels:

AIDS and HIV

Add to Favorites Subscribe Share
fbshare-AIDS and HIV

Showing results

4150 of 1307
  • Embargo expired:
    24-Mar-2019 11:00 AM EDT

Article ID: 709716

Exposure to HIV Virus, Treatment Before Birth Linked to Obesity Later in Life

Endocrine Society

Teens and young adults who were exposed to HIV and antiretroviral therapy before birth but are HIV-negative themselves are at increased risk of obesity and asthma-like symptoms, according to research to be presented Saturday, March 23 at ENDO 2019, the Endocrine Society’s annual meeting in New Orleans, La.

Released:
20-Mar-2019 9:00 AM EDT
AMSSM Logo.jpg

Article ID: 710030

AMSSM Releases Updated Position Statement on Blood-borne Pathogens in the Context of Sports Participation

American Medical Society for Sports Medicine (AMSSM)

There have been significant advances in clinical and scientific research in the understanding of blood-borne pathogens (BBPs), which are pathogenic microorganisms that are present in human blood and can cause disease in humans. These pathogens include, but are not limited to, hepatitis C virus (HCV), hepatitis D virus (HDV) and human immunodeficiency virus (HIV). Updating a statement from 1995, this document is intended as a general guide to clinical practice based on the current state of evidence, while acknowledging the need for modification as new knowledge becomes available.

Released:
21-Mar-2019 12:05 PM EDT
PennMed_logo.png

Article ID: 710026

Naltrexone Implant Helps HIV Patients with Opioid Dependence Adhere to Medications, Prevent Relapse

Perelman School of Medicine at the University of Pennsylvania

A new study, published this month in Lancet HIV by Penn Medicine researchers, shows that a naltrexone implant placed under the skin was more effective at helping HIV-positive patients with an opioid addiction reduce relapse and have better HIV-related outcomes compared to the oral drug.

Released:
21-Mar-2019 12:00 PM EDT

Article ID: 709613

Shield Diagnostics announces launch of Target-NG test for antibiotic susceptibility in Neisseria gonorrhoeae

Shield Diagnostics

Shield Diagnostics, an Andreessen Horowitz-backed clinical laboratory tackling antibiotic resistance by bringing precision medicine to infectious disease, announced the launch of Target-NG, a rapid molecular test for antibiotic susceptibility in Neisseria gonorrhoeae.

Released:
14-Mar-2019 4:05 AM EDT
NYUlogoLarge2597.png

Article ID: 709561

NYU College of Dentistry Awarded $2 Million NIH Grant to Study HIV Latency

New York University

The National Institute of Allergy and Infectious Diseases awarded a grant to researchers at New York University College of Dentistry to study HIV latency. The grant provides nearly $2 million over five years to support research led by David N. Levy, PhD, associate professor of basic science and craniofacial biology at NYU Dentistry.

Released:
13-Mar-2019 12:05 PM EDT

Article ID: 709376

Dr. Sharon Hillier to Receive 2019 Women who RockTM Award

Magee-Womens Research Institute

The 2019 Pittsburgh Women who Rock Award will be presented to Sharon L. Hillier, Ph.D., at the 3rd annual Women who Rock Benefit Concert Presented by UPMC Health Plan and UPMC Magee-Womens Hospital on Thursday, May 30, at Stage AE. Dr. Hillier is professor and vice chair of the department of obstetrics

Released:
11-Mar-2019 8:50 AM EDT
Newswise: Johns Hopkins Experts to Present Latest TB and HIV Research at CROI 2019

Article ID: 709206

Johns Hopkins Experts to Present Latest TB and HIV Research at CROI 2019

Johns Hopkins Medicine

Johns Hopkins Medicine researchers are attending the annual Conference on Retroviruses and Opportunistic Infections (CROI), where they are sharing their latest findings in the ongoing battle against HIV/AIDS and related infectious diseases with other top basic, translational and clinical researchers from around the world. This year’s conference is being held March 4 to 7 at the Washington State Convention Center in Seattle.

Released:
6-Mar-2019 2:45 PM EST
JHSPH-new-logo.jpg

Article ID: 709132

Heroin Users Aware of Fentanyl, But At High Risk of Overdosing

Johns Hopkins Bloomberg School of Public Health

Most heroin users in Baltimore, a city heavily affected by the opioid epidemic, recognize that the heroin they buy is now almost always laced with the highly dangerous synthetic opioid fentanyl, according to a new study led by researchers at the Johns Hopkins Bloomberg School of Public Health.

Released:
5-Mar-2019 12:05 PM EST

Showing results

4150 of 1307

Chat now!